NSAM
HAE icon

North Star Asset Management’s Haemonetics HAE Stock Holding History

North Star Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,800
Closed -$322K – 261
2019
Q4 		$322K Sell
2,800
-500
-15% -$60.5K 0.02% 232
2019
Q3 		$416K Hold
3,300
– – 0.03% 206
2019
Q2 		$397K Hold
3,300
– – 0.03% 214
2019
Q1 		$289K Hold
3,300
– – 0.02% 240
2018
Q4 		$330K Hold
3,300
– – 0.03% 219
2018
Q3 		$378K Hold
3,300
– – 0.03% 222
2018
Q2 		$296K Sell
3,300
-200
-6% -$16.9K 0.03% 238
2018
Q1 		$256K Sell
3,500
-300
-8% -$20.6K 0.02% 249
2017
Q4 		$221K Sell
3,800
-6,750
-64% -$355K 0.02% 261
2017
Q3 		$473K Sell
10,550
-12,410
-54% -$516K 0.05% 184
2017
Q2 		$907K Sell
22,960
-10,685
-32% -$439K 0.09% 152
2017
Q1 		$1.36M Sell
33,645
-73,195
-69% -$2.86M 0.14% 130
2016
Q4 		$4.29M Sell
106,840
-97,420
-48% -$3.67M 0.47% 80
2016
Q3 		$7.4M Sell
204,260
-16,790
-8% -$576K 0.83% 43
2016
Q2 		$6.41M Buy
221,050
+13,600
+7% +$411K 0.75% 55
2016
Q1 		$7.26M Buy
207,450
+3,170
+2% +$102K 0.85% 44
2015
Q4 		$6.59M Sell
204,280
-9,751
-5% -$316K 0.79% 46
2015
Q3 		$6.92M Buy
214,031
+21,160
+11% +$796K 0.86% 42
2015
Q2 		$7.98M Buy
192,871
+5,830
+3% +$246K 0.91% 39
2015
Q1 		$8.4M Sell
187,041
-130
-0.1% -$5.43K 0.95% 33
2014
Q4 		$7M Buy
187,171
+3,705
+2% +$136K 0.8% 49
2014
Q3 		$6.41M Buy
183,466
+14,255
+8% +$509K 0.76% 51
2014
Q2 		$5.97M Buy
169,211
+11,571
+7% +$387K 0.7% 57
2014
Q1 		$5.14M Buy
157,640
+57,610
+58% +$2.2M 0.62% 60
2013
Q4 		$4.21M Buy
100,030
+16,100
+19% +$663K 0.51% 71
2013
Q3 		$3.35M Buy
83,930
+29,600
+54% +$1.24M 0.44% 82
2013
Q2 		$2.25M Buy
+54,330
New +$2.2M 0.31% 102

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

North Star Asset Management's HAE Position: Q1 2020 in Review

North Star Asset Management sold out of Haemonetics (HAE) in Q1 2020, closing a stake of 2,800 shares — an estimated $322K sold.

North Star Asset Management first reported a position in HAE in Q2 2013 and held it in 27 quarters. The position peaked at $8.4M in Q1 2015. 269 funds tracked by Wall St. Rank hold HAE as of Q1 2020.

  • North Star Asset Management reported no remaining Haemonetics position as of Q1 2020 after selling out during the quarter.
  • North Star Asset Management sold 2,800 Haemonetics shares in Q1 2020, an estimated $322K.
  • North Star Asset Management first reported a position in Haemonetics in Q2 2013 and held it in 27 quarters.
  • North Star Asset Management's Haemonetics position peaked at $8.4M in Q1 2015.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q1 2020.

Based on North Star Asset Management's 13F filing for Q1 2020, filed 24 Apr 2020.